Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms

Figures & data

Figure 1. Mutational landscape of the cohort.

Figure 2. The overall survival rates stratified by R-IPSS (A) and M-IPSS (B).

Table 1. The frequencies of patients, hazard ratios (HR) with 95% confidence interval (CI) and Concordance Index (C-index) as classified by R-IPSS score and M-IPSS score.

	Frequency (%)	HR (95%CI)	P-value	C-index (95%CI)
R-IPSS
• Very low	25 (15.4)	1	Ref
• Low	63 (38.9)	3.49 (1.05–11.6)	0.04
• Intermediate	30 (18.5)	3.35 (0.95–11.8)	0.06	0.71 (0.64–0.78)
• High	24 (14.8)	12.64 (3.69–43.3)	<0.001
• Very High	20 (12.3)	17.74 (5.12–61.4)	<0.001
M-IPSS
• Very low	14 (8.6)	1	Ref
• Low	53 (32.7)	1.76 (0.39–7.9)	0.46
• Moderate low	30 (18.5)	3.47 (0.79–15.2)	0.10	0.75 (0.69–0.80)
• Moderate high	8 (4.9)	2.17 (0.36–13)	0.40
• High	26 (16)	8.43 (1.97–36.1)	0.004
• Very High	31 (19.1)	16.67 (3.89–71.3)	<0.001